Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.406SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.115SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.133SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.466SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.489SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.363SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.95SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.531SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.45SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.200SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.299SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.55SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.149SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.300SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.179SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.125SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
G.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.438SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.35SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.178SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.208SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.197SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.491SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.8 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.75.3 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FR.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBJ.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GJ.1.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CM.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBC.1.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XDLSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.29.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.29.2 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.10.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.10.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.56SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GA.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.1.10.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used